FR2159413A1 - - Google Patents

Info

Publication number
FR2159413A1
FR2159413A1 FR7239713A FR7239713A FR2159413A1 FR 2159413 A1 FR2159413 A1 FR 2159413A1 FR 7239713 A FR7239713 A FR 7239713A FR 7239713 A FR7239713 A FR 7239713A FR 2159413 A1 FR2159413 A1 FR 2159413A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7239713A
Other versions
FR2159413B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2159413A1 publication Critical patent/FR2159413A1/fr
Application granted granted Critical
Publication of FR2159413B1 publication Critical patent/FR2159413B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7239713A 1971-11-11 1972-11-09 Expired FR2159413B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1637771 1971-11-11
CH1354572 1972-09-15

Publications (2)

Publication Number Publication Date
FR2159413A1 true FR2159413A1 (fr) 1973-06-22
FR2159413B1 FR2159413B1 (fr) 1975-08-08

Family

ID=25712489

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7239713A Expired FR2159413B1 (fr) 1971-11-11 1972-11-09

Country Status (9)

Country Link
US (1) US3883656A (fr)
AU (1) AU4864272A (fr)
BE (1) BE791253A (fr)
DE (1) DE2254018A1 (fr)
FR (1) FR2159413B1 (fr)
GB (1) GB1405949A (fr)
IE (1) IE36780B1 (fr)
IL (1) IL40597A (fr)
NL (1) NL7214607A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0038060A1 (fr) * 1980-04-14 1981-10-21 Merck & Co. Inc. Composition pharmaceutique contenant du L-alpha méthyl-dihydroxy-3,4 phénylalanine et du salicylamide pour le traitement de l'hypertension

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389415A (en) * 1978-01-24 1983-06-21 Merck & Co., Inc. Method of treating hypertension
EP0374764B1 (fr) * 1988-12-19 2001-04-04 Nec Corporation Appareil de transmission de données

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0038060A1 (fr) * 1980-04-14 1981-10-21 Merck & Co. Inc. Composition pharmaceutique contenant du L-alpha méthyl-dihydroxy-3,4 phénylalanine et du salicylamide pour le traitement de l'hypertension

Also Published As

Publication number Publication date
IL40597A0 (en) 1972-12-29
GB1405949A (en) 1975-09-10
IL40597A (en) 1976-06-30
US3883656A (en) 1975-05-13
DE2254018A1 (de) 1973-05-30
NL7214607A (fr) 1973-05-15
FR2159413B1 (fr) 1975-08-08
BE791253A (fr) 1973-05-10
IE36780B1 (en) 1977-02-16
IE36780L (en) 1973-05-11
AU472689B2 (fr) 1976-06-03
AU4864272A (en) 1974-05-09

Similar Documents

Publication Publication Date Title
ATA136472A (fr)
AR196074A1 (fr)
AU2658571A (fr)
AU2691671A (fr)
AU2485671A (fr)
AU3005371A (fr)
AU2952271A (fr)
AU2941471A (fr)
AU2894671A (fr)
AU2742671A (fr)
AU2684071A (fr)
AU2564071A (fr)
AU2473671A (fr)
AU2755871A (fr)
AU2486471A (fr)
AU3038671A (fr)
AU2503871A (fr)
AR192311Q (fr)
AU2577671A (fr)
AU2588771A (fr)
AU2654071A (fr)
AU2456871A (fr)
AU2669471A (fr)
AU2455871A (fr)
AU2684171A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse